Lechi Ye
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
Papers in
- Oncology 16
- Colorectal Cancer Treatments and Studies 6
- Colorectal Cancer Surgical Treatments 3
- Cytokine Signaling Pathways and Interactions 3
-
- RNA modifications and cancer 4
- Co-authors
- Ye Wei (15 shared papers)Jianmin Xu (12 shared papers)Dexiang Zhu (14 shared papers)Li Ren (12 shared papers)Juji Dai (4 shared papers)Qing‐Hai Ye (5 shared papers)Wei Cen (7 shared papers)Junjun Qiu (4 shared papers)
- Journals
- PLoS ONE (4 papers)Journal of Clinical Oncology (3 papers)Annals of Surgical Oncology (3 papers)Tumor Biology (3 papers)Cell Death and Disease (2 papers)
- Partner nations
- ChinaUnited StatesIsrael
In The Last Decade
Lechi Ye
47 papers receiving 1.5k citations
Lechi Ye's Hit Papers
Peers
Comparison fields: 5 of 85
- Hepatology 294
- Cancer Research 458
- Oncology 427
- Pulmonary and Respiratory Medicine 294
- Molecular Biology 524
Countries citing papers authored by Lechi Ye
This map shows the geographic impact of Lechi Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lechi Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lechi Ye more than expected).
Fields of papers citing papers by Lechi Ye
This network shows the impact of papers produced by Lechi Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lechi Ye. The network helps show where Lechi Ye may publish in the future.
Co-authors
The 25 scholars most cited alongside Lechi Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 298 | |
| 2 | Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer Hit paper breakdown → | 2021 | 238 |
| 3 | 2014 | 199 | |
| 4 | 2012 | 73 | |
| 5 | 2016 | 61 | |
| 6 | 2014 | 46 | |
| 7 | 2016 | 40 | |
| 8 | 2014 | 37 | |
| 9 | 2015 | 36 | |
| 10 | 2014 | 34 | |
| 11 | 2015 | 34 | |
| 12 | 2015 | 32 | |
| 13 | 2023 | 29 | |
| 14 | 2017 | 23 | |
| 15 | 2017 | 23 | |
| 16 | 2014 | 23 | |
| 17 | 2015 | 22 | |
| 18 | 2015 | 19 | |
| 19 | 2015 | 17 | |
| 20 | 2019 | 17 |
About Lechi Ye
Lechi Ye is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Hepatology and Cancer Research, having authored 48 papers that have together received 1.5k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Colorectal Cancer Treatments and Studies (6 papers), Autophagy in Disease and Therapy (4 papers), RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (4 papers), Ferroptosis and cancer prognosis (3 papers), Colorectal Cancer Surgical Treatments (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). The work is most often cited by research in Hepatology (294 citations), Cancer Research (458 citations), Oncology (427 citations), Pulmonary and Respiratory Medicine (294 citations) and Molecular Biology (524 citations). Lechi Ye has collaborated with scholars based in China, United States and Israel. Frequent co-authors include Ye Wei, Jianmin Xu, Dexiang Zhu, Li Ren, Juji Dai, Qing‐Hai Ye, Wei Cen, Junjun Qiu, Bo Xu and Tianshu Liu. Their work appears in journals such as PLoS ONE, Journal of Clinical Oncology, Annals of Surgical Oncology, Tumor Biology and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.